Chapter 3 66 References 1. Ou, Z. et al. Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson’s Disease in 204 Countries/Territories From 1990 to 2019. Frontiers in Public Health 9, (2021). 2. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 17, 939–953 (2018). 3. Ophey, A., Eggers, C., Dano, R., Timmermann, L. & Kalbe, E. Health-Related Quality of Life Subdomains in Patients with Parkinson’s Disease: The Role of Gender. Parkinsons Dis. 2018, (2018). 4. Siddiqi, B. & Koemeter-Cox, A. A Call to Action: Promoting Diversity, Equity, and Inclusion in Parkinson’s Research and Care. J. Parkinsons. Dis. 11, 905–908 (2021). 5. Tosserams, A. et al. Underrepresentation of women in Parkinson’s disease trials. Movement disorders : official journal of the Movement Disorder Society vol. 33 1825–1826 Preprint at https:// doi.org/10.1002/mds.27505 (2018). 6. Schneider, M. G. et al. Minority enrollment in Parkinson’s disease clinical trials. Parkinsonism Relat. Disord. 15, 258–262 (2009). 7. Lau, Y. H. et al. Does Ethnicity Influence Recruitment into Clinical Trials of Parkinson’s Disease? J. Parkinsons. Dis. (2022) doi:10.3233/JPD-213113. 8. Iwaki, H. et al. Differences in the Presentation and Progression of Parkinson’s Disease by Sex. Mov. Disord. 36, 106–117 (2021). 9. Picillo, M. et al. The relevance of gender in Parkinson’s disease: a review. J. Neurol. 264, 1583–1607 (2017). 10. Georgiev, D., Hamberg, K., Hariz, M., Forsgren, L. & Hariz, G.-M. Gender differences in Parkinson’s disease: A clinical perspective. Acta Neurol. Scand. 136, 570–584 (2017). 11. Crispino, P. et al. Gender Differences and Quality of Life in Parkinson ’ s Disease. International Journal of Environmental Research and Public Health (2021). 12. Pavon, J. M., Whitson, H. E. & Okun, M. S. Parkinson’s disease in women: a call for improved clinical studies and for comparative effectiveness research. Maturitas 65, 352–358 (2010). 13. Bartz, D. et al. Clinical Advances in Sex- and Gender-Informed Medicine to Improve the Health of All: A Review. JAMA Intern. Med. 180, 574–583 (2020). 14. Krieger, N. Genders, sexes, and health: What are the connections - And why does it matter? Int. J. Epidemiol. 32, 652–657 (2003). 15. Annandale, E. & Hunt, K. Gender inequalities in health: research at the crossroads. vol. 1 1–35 (2000). 16. Balash, Y., Korczyn, A. D., Migirov, A. A. & Gurevich, T. Quality of life in Parkinson’s disease: A genderspecific perspective. Acta Neurol. Scand. 140, 17–22 (2019). 17. Abraham, D. S. et al. Sex differences in Parkinson’s disease presentation and progression. Parkinsonism Relat. Disord. 69, 48–54 (2019). 18. Martínez-Martín, P. An introduction to the concept of quality of life in Parkinson’s disease. Journal of neurology 245 Suppl, 2–6 (1998). 19. Ypinga, J. H. L. et al. Rationale and design to evaluate the PRIME Parkinson care model : a prospective observational evaluation of proactive , integrated and patient ‑ centred Parkinson care in The Netherlands ( PRIME ‑ NL ). BMC Neurol. 1–11 (2021) doi:10.1186/s12883-021-02308-3. 20. Lindqvist, A., Sendén, M. G. & Renström, E. A. What is gender, anyway: a review of the options for operationalising gender. Psychology and Sexuality 00, 1–13 (2020).
RkJQdWJsaXNoZXIy MTk4NDMw